Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience

Vanessa Nader; Anthony Matta; Ronan Canitrot; Romain Itier; Pascale Salameh; Olivier Lairez; Meyer Elbaz; Michel Galinier; Rania Azar; Jerome Roncalli

doi:10.12659/MSM.928218

09 February 2021: Clinical Research

Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience

Vanessa Nader ^12ABCDEF , Anthony Matta ^13ABDEF , Ronan Canitrot ^1ADEF , Romain Itier ^1DEF , Pascale Salemeh ^2ACF , Olivier Lairez ^1EF , Meyer Elbaz ^1AEF , Michel Galinier ^1AEF , Rania Azar ^2ADEF , Jerome Roncalli ^1ADEF*

DOI: 10.12659/MSM.928218

Med Sci Monit 2021; 27:e928218

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 2 Prevalence of valvular heart disease and left ventricular dysfunction according to several cardiovascular risk factors.

	Sex		Age		Smoker		AH		DLP		DM

	Male	Female	[18–65]	>65	No	Yes	No	Yes	No	Yes	No	Yes
	1740	1340	1660	1420	2300	780	2515	565	2510	570	2520	560
	68%	69%	72%	64%	88%	41%	80%	42%	72%	55%	72%	54%

	835	605	635	805	320	1120	650	790	965	475	960	480
	32%	31%	28%	36%	12%	59%	21%	58%	28%	46%	28%	46%

	0.36

	1970	1510	1765	1715	2340	1140	2640	840	2745	735	2760	720
	77%	78%	77%	77%	89%	60%	83%	62%	79%	70%	79%	69%

	605	435	530	510	280	760	525	515	730	310	720	320
	23%	22%	23%	23%	11%	40%	17%	38%	21%	30%	21%	31%

	0.39		0.96

	2365	1755	2180	1940	2595	1525	3050	1070	3250	870	3245	875
	92%	90%	95%	87%	99%	80%	96%	79%	94%	83%	93%	84%

	210	190	115	285	25	375	115	285	225	175	235	165
	8%	10%	5%	13%	1%	20%	4%	21%	7%	17%	7%	16%

	0.06

	1345	1025	1260	1110	1550	820	1810	560	1890	480	1920	450
	52%	53%	55%	50%	59%	43%	57%	41%	55%	46%	55%	43%

	1230	920	1035	1115	1070	1080	1355	795	1585	565	1560	590
	48%	47%	45%	50%	41%	57%	43%	59%	46%	54%	45%	57%

	0.76

	1380	1040	1280	1140	1575	845	1830	590	1935	485	1965	455
	53.6%	53.5%	56%	52%	60%	45%	58%	44%	56%	46%	57%	44%

	1195	905	1015	1085	1045	1055	1335	765	1540	560	1515	585
	46.4%	46.5%	44%	49%	40%	56%	42%	57%	44%	54%	44%	56%

	0.91		0.002

	2550	1920	2285	2185	2605	1865	3150	1320	3435	1035	3440	1030
	99%	99%	99%	98%	99%	98%	99%	97%	99%	99%	99%	99%

	25	25	10	40	15	35	15	35	40	10	40	10
	1%	1%	1%	2%	1%	2%	1%	3%	1%	1%	1%	1%

	0.32								0.6		0.61

	2020	1530	1860	1690	2385	1165	2720	830	2815	735	2820	730
	78%	79%	81%	76%	91%	61%	86%	61%	81%	70%	81%	70%

	555	415	435	535	235	735	445	525	660	310	660	310
	22%	21%	19%	24%	9%	39%	14%	39%	19%	30%	19%	30%

	0.86

	1520	1130	1400	1250	1640	1010	1950	700	2045	605	2035	615
	59%	58%	61%	56%	63%	53%	62%	52%	59%	58%	59%	59%

	1055	815	895	975	980	890	1215	655	1430	440	1445	425
	41%	42%	39%	44%	37%	47%	38%	48%	41%	42%	42%	41%

	0.53								0.58		0.7

	1080	735	1025	790	1175	640	1370	445	1400	415	1405	410
	42%	38%	45%	36%	45%	34%	43%	33%	40%	40%	40%	39%

	1495	1210	1270	1435	1445	1260	1795	910	2075	630	2075	630
	58%	62%	55%	65%	55%	66%	57%	67%	60%	60%	60%	61%

	0.005								0.74		0.58

	2000	1710	1935	1775	2150	1560	2615	1095	2875	835	2865	845
	78%	88%	84%	80%	82%	82%	83%	81%	83%	80%	82%	81%

	575	235	360	450	470	340	550	260	600	210	615	195
	22%	12%	16%	20%	18%	18%	17%	19%	17%	20%	18%	19%

					0.97		0.14		0.03		0.42
AH – arterial hypertension; AMVD – aorto-mitral valve disease; AVR – aortic valve regurgitation; AVS – aortic valve stenosis; DD – diastolic dysfunction; DLP – dyslipidemia; DM – diabetes mellitus; MVD – mitral valve disease; MVR – mitral valve regurgitation; MVS – mitral valve stenosis; R – tricuspid regurgitation; SD – systolic dysfunction; TAVD – aortic valve disease.

Back to the Article

Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience

Your Privacy